case_images: PMC10442482_01
case_images: Mean transprosthetic gradient immediately after TAVR, measured by TTE.
case_images: fcvm-10-1164432-g001.jpg
case_images: PMC10442482_01_fcvm-10-1164432-g001.jpg
case_images: F1
case_images: The mean transprosthetic gradient assessed by transthoracic echocardiography (TTE) was 5 mmHg (Figure 1), and the patient was discharged home on day 4 under dual antiplatelet therapy with aspirin and clopidogrel in the context of recent percutaneous coronary intervention (PCI).
case_images: Mean transprosthetic gradient at diagnosis of HIT, assessed by TTE.
case_images: fcvm-10-1164432-g002.jpg
case_images: PMC10442482_01_fcvm-10-1164432-g002.jpg
case_images: F2
case_images: By TTE, aortic valve thrombosis was suspected with significant elevation of the mean transprosthetic gradient at 28 mmHg and reduced leaflet motion of the right coronary cusp (Figure 2).
case_images: Cardiac tomography that shows a hypodense thickening of aortic cusps, confirming diagnosis of valve thrombosis, in sagittal (A) and transversal (B) views.
case_images: fcvm-10-1164432-g003.jpg
case_images: PMC10442482_01_fcvm-10-1164432-g003.jpg
case_images: F3
case_images: Cardiac tomography was performed that confirmed the diagnosis of bioprosthetic valve thrombosis with a hypodense thickening of the aortic cusps (Figure 3).
case_images: Mean transprosthetic gradient at discharge, after treatment with argatroban and initiation of Coumadin.
case_images: fcvm-10-1164432-g004.jpg
case_images: PMC10442482_01_fcvm-10-1164432-g004.jpg
case_images: F4
case_images: Cardiac echocardiography after 1 week of treatment with argatroban revealed a significant decrease in the mean transprosthetic gradient of 9 mmHg (Figure 4).